Population pharmacokinetic analysis of a long-acting recombinant factor IX-FC fusion protein (RFIXFC) in patients with severe haemophilia B

被引：0
|
作者：
Diao, L. [1 ]
Li, S. [2 ]
Nestorov, I. [3 ]
Jiang, H. [2 ]
机构：
[1] Biogen Idec Hemophilia, Waltham, MA USA
[2] Biogen Idec Hemophilia, Preclin & Clin Res, Waltham, MA USA
[3] Biogen Idec Inc, Pharmacometr, Cambridge, MA USA
来源：
HAEMOPHILIA | 2013年 / 19卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：33 / 33
页数：1
相关论文
共 50 条
  • [1] Population Pharmacokinetic Modelling of Recombinant Factor IX Fc Fusion Protein (rFIXFc) in Patients with Haemophilia B
    Diao, Lei
    Li, Shuanglian
    Ludden, Thomas
    Gobburu, Jogarao
    Nestorov, Ivan
    Jiang, Haiyan
    CLINICAL PHARMACOKINETICS, 2014, 53 (05) : 467 - 477
  • [2] Population Pharmacokinetic Modelling of Recombinant Factor IX Fc Fusion Protein (rFIXFc) in Patients with Haemophilia B
    Lei Diao
    Shuanglian Li
    Thomas Ludden
    Jogarao Gobburu
    Ivan Nestorov
    Haiyan Jiang
    Clinical Pharmacokinetics, 2014, 53 : 467 - 477
  • [3] Long-acting recombinant factor IX Fc fusion protein (rFIXFc) for perioperative management of subjects with haemophilia B in the phase 3 B-LONG study
    Powell, Jerry S.
    Apte, Shashikant
    Chambost, Herve
    Hermans, Cedric
    Jackson, Shannon
    Josephson, Neil C.
    Mahlangu, Johnny N.
    Ozelo, Margareth C.
    Peerlinck, Kathelijne
    Pasi, John
    Perry, David
    Ragni, Margaret V.
    Wang, Xuefeng
    Jiang, Haiyan
    Li, Shuanglian
    Cristiano, Lynda M.
    Innes, Alison
    Nugent, Karen
    Brennan, Aoife
    Luk, Alvin
    Allen, Geoffrey
    Pierce, Glenn F.
    Robinson, Brian
    BRITISH JOURNAL OF HAEMATOLOGY, 2015, 168 (01) : 124 - 134
  • [4] Clinical trial for long-lasting recombinant factor IX-FC (rFIXFc) in subjects with haemophilia B (B-LONG)
    Luk, A.
    Jiang, H.
    Gust, S.
    Defeo-Fraulini, T.
    Roberts, A.
    Pierce, G.
    HAEMOPHILIA, 2011, 17 (02) : 355 - 355
  • [5] A new population pharmacokinetic model for recombinant factor IX-Fc fusion concentrate including young children with haemophilia B
    Koopman, Sjoerd F.
    Goedhart, Tine M. H. J.
    Bukkems, Laura H.
    Mulders, Trevor M.
    Leebeek, Frank W. G.
    Fijnvandraat, Karin
    Coppens, Michiel
    Mathias, Mary
    Collins, Peter W.
    Tait, R. Campbell
    Bagot, Catherine N.
    Curry, Nicola
    Payne, Jeanette
    Chowdary, Pratima
    Cnossen, Marjon H.
    Mathot, Ron A. A.
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2024, 90 (01) : 220 - 231
  • [6] Assessment of recombinant factor IX-FC fusion protein (RFIXFC) clotting activity in plasma samples at canadian haemophilia treatment centres
    Geske, Jon F.
    Sadeghi-Khomami, A.
    Chaudhry, H. R.
    Sholzberg, M.
    Teitel, J.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2015, 13 : 316 - 316
  • [7] Population pharmacokinetic analysis of long-lasting recombinant factor VIII Fc fusion protein (rFVIIIFc) in patients with severe haemophilia A
    Neelakantan, S.
    Li, S.
    Powell, J.
    Josephson, N.
    Pasi, J.
    Perry, D.
    Shapiro, A. D.
    Ragni, M.
    Kulkarni, R.
    Fogarty, P.
    Brennan, A.
    Pierce, G.
    Jiang, H.
    Nestorov, I
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2013, 11 : 354 - 355
  • [8] Population pharmacokinetics of a new long-acting recombinant coagulation factor IX albumin fusion protein for patients with severe hemophilia B
    Zhang, Y.
    Roberts, J.
    Bensen-Kennedy, D.
    Jacobs, I.
    Santagostino, E.
    Voigt, C.
    Feussner, A.
    Morfini, M.
    Sidhu, J.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2016, 14 (11) : 2132 - 2140
  • [9] Long-acting recombinant factor VIII Fc fusion protein (rFVIIIFc) for perioperative haemostatic management in severe haemophilia A
    Mahlangu, Johnny N.
    Ragni, Margaret
    Gupta, Naresh
    Rangarajan, Savita
    Klamroth, Robert
    Oldenburg, Johannes
    Nogami, Keiji
    Young, Guy
    Cristiano, Lynda M.
    Dong, Yingwen
    Allen, Geoffrey
    Pierce, Glenn F.
    Robinson, Brian
    THROMBOSIS AND HAEMOSTASIS, 2016, 116 (01) : 1 - 8
  • [10] Subject-Reported Changes in Physical Activity During The B-LONG Study of Recombinant Factor IX FC Fusion Protein (RFIXFC) For Severe Haemophilia B
    Windyga, J.
    Ragni, M.
    Pasi, J.
    Shapiro, A. D.
    Ozelo, M.
    Innes, A.
    Mei, B.
    HAEMOPHILIA, 2015, 21 : 29 - 29
12345